Affymetrix to Use TriLink Oligos in Kits | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix will use TriLink Biotechnologies' oligonucleotides in several of its kits under an agreement announced today by the firms.

The partners did not disclose terms of the agreement, but said it is a multi-year distribution and supply pact. They also did not specify which Affy kits would contain the oligos.

San Diego-based TriLink makes custom oligos, modified nucleoside triphosphates and CleanAmp PCR products for the diagnostics and OEM markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.